Resultats de la cerca - Atto Billio
- Mostrar 1 - 5 resultats de 5
-
1
Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine Combination Treatment for Patients With Waldenström Macroglobulinemia: Clinical and Biologic Results of a Phase II Multicenter... per Daniele Laszlò, Giovanna Andreola, Luigi Rigacci, Alberto Fabbri, Cristina Rabascio, Patrizia Mancuso, Giancarlo Pruneri, Davide Radice, Antonio Pinto, Ferdinando Frigeri, Liliana Calabrese, Atto Billio, Francesco Bertolini, Giovanni Martinelli
Publicat 2010Artigo -
2
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospectiv... per Andrea Gallamini, Francesco Zaja, Caterina Patti, Atto Billio, Maria Rosaria Specchia, Alessandra Tucci, Alessandro Levis, Annunziata Manna, V. E. M. Rosso Di San Secondo, Luigi Rigacci, Antonio Pinto, Emilio Iannitto, Valerio Zoli, Alessandro Federico, Stefano Pileri, Corrado Tarella
Publicat 2007Artigo -
3
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG per Attilio Olivieri, Gino Santini, Caterina Patti, Teodoro Chisesi, Cármino Antônio De Souza, A. Rubagotti, Savina Aversa, Atto Billio, Antonio Porcellini, Marco Candela, Riccardo Centurioni, A Congiu, Marino Brunori, S Nati, Mauro Spriano, R. Vimercati, Gloria E. Marino, A. Contu, L. Tedeschi, Ignazio Majolino, Monica Crugnola, M.R. Sertoli
Publicat 2005Artigo -
4
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas per Sergio Cortelazzo, Corrado Tarella, Alessandro M. Gianni, Marco Ladetto, Anna Maria Barbui, Andrea Rossi, Giuseppe Gritti, Paolo Corradini, Massimo Di Nicola, Caterina Patti, Antonino Mulè, Manuela Zanni, Valerio Zoli, Atto Billio, Andrea Piccin, Giovanni Negri, Claudia Castellino, Francesco Di Raimondo, Andrés J.M. Ferreri, Fabio Benedetti, Giorgio La Nasa, Guido Gini, Livio Trentin, Maurizio Frezzato, Leonardo Flenghi, Simona Falorio, Marco Chilosi, Riccardo Bruna, Valentina Tabanelli, Stefano Pileri, Arianna Masciulli, Federica Delaini, Cristina Boschini, Alessandro Rambaldi
Publicat 2016Artigo -
5
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study per Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, Riccardo Bruna, Michèle Cavo, Francesco Merli, Emanuele Angelucci, Mauro Krampera, Roberto Cairoli, Matteo Giovanni Della Porta, Nicola Stefano Fracchiolla, Marco Ladetto, Carlo Gambacorti‐Passerini, Marco Salvini, Monia Marchetti, Roberto M. Lemoli, Alfredo Molteni, Alessandro Busca, Antonio Cuneo, Alessandra Romano, Nicola Giuliani, Sara Galimberti, Alessandro Corso, Alessandro Morotti, Brunangelo Falini, Atto Billio, Filíppo Gherlinzoni, Giuseppe Visani, Maria Chiara Tisi, Agostino Tafuri, Patrizia Tosi, Francesco Lanza, Massimo Massaia, Mauro Turrini, Felicetto Ferrara, Carmela Gurrieri, Daniele Vallisa, Maurizio Martelli, Enrico Derenzini, Attilio Guarini, Annarita Conconi, Annarosa Cuccaro, Laura Cudillo, Domenico Russo, Fabrizio Ciambelli, Anna Maria Scattolin, Mario Luppi, Carmine Selleri, Elettra Ortu La Barbera, Celestino Ferrandina, Nicola Di Renzo, Attilio Olivieri, Monica Bocchia, Massimo Gentile, Francesco Marchesi, Pellegrino Musto, Augusto B. Federici, Anna Candoni, Adriano Venditti, Carmen Fava, Antonio Pinto, Piero Galieni, Luigi Rigacci, Daniele Armiento, Fabrizio Pane, Margherita Oberti, Patrizia Zappasodi, Carlo Visco, Matteo Franchi, Paolo Grossi, Lorenza Bertù, Giovanni Corrao, Livio Pagano, Paolo Corradini
Publicat 2020Artigo
Eines de cerca:
Matèries relacionades
Internal medicine
Medicine
Lymphoma
Rituximab
Chemotherapy
Cyclophosphamide
Gastroenterology
Oncology
Prednisone
Surgery
Vincristine
CHOP
2019-20 coronavirus outbreak
Aggressive lymphoma
Autologous stem-cell transplantation
Chemotherapy regimen
Clinical endpoint
Clinical trial
Cohort
Cohort study
Coronavirus disease 2019 (COVID-19)
Diffuse large B-cell lymphoma
Disease
Etoposide
Infectious disease (medical specialty)
Intensive care medicine
International Prognostic Index
Lymphoplasmacytic Lymphoma
Macroglobulinemia
Multiple myeloma